At ASCO Day 3, AstraZeneca dominates, Takeda reveals experimental drug data, Eli Lilly serves salad

At ASCO Day 3, AstraZeneca dominates, Takeda reveals experimental drug data, Eli Lilly serves salad

On ASCO Day 3, AstraZeneca is dominant (again), Protagonist Therapeutics and Takeda review blood cancer data, and more.

AstraZeneca Highlights Lung Cancer Advances While Takeda Shares Early Data on Experimental Therapy at ASCO Meeting

On the third day of the American Society of Clinical On […] The post AstraZeneca Highlights Lung Cancer Advances While Takeda Shares Early Data on Experimental Therapy at ASCO Meeting first appeared on GeneOnline News. The post AstraZeneca Highlights Lung Cancer Advances While Takeda Shares Early Data on Experimental Therapy at ASCO Meeting appeared first on GeneOnline News.

STAT+: At ASCO Day 3, AstraZeneca dominates, Takeda reveals experimental drug data, Eli Lilly serves salad – RamaOnHealthcare

The SERD spectacle, the VERIFY study, and the dream of a better multi-cancer liquid biopsy testWe’re going to get to today’s new data in a minute, but first let’s deal with a less serious matter: the marketing of pharmaceutical products via the food attendees need to consume at giant medical meetings.Genentech has been a longtime [...]